When someone is diagnosed with brain cancer, we evaluate whether that patient can benefit from one of our current clinical trials. We welcome and will evaluate all patients, even if they’ve been evaluated or treated by other physicians or institutions.
If you have already undergone a biopsy, we recommend that you send us your tissue samples for tissue microarray analysis to determine effectiveness of the chemotherapy regimens. This new and innovative part of our program can offer better insights into treatments.
Clinical Trials for Newly Diagnosed Tumors
- DCVax®-L Vaccine
- HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM (HeatShock)
- Rindopepimut (CDX-110) Vaccine
Malignant Tumor Types